Impact of the frequency of plasma HIV-1 RNA monitoring on the outcome of antiretroviral therapy
Background: Current guidelines for HIV management recommend monitoring plasma HIV-1 RNA level every 3-6 months in patients on a stable antiretroviral regimen. However, cost is the major obstacle to follow the guidelines in resource-limited settings. Objective: This study aimed to compare the outcome...
Saved in:
Main Authors: | Chaiwarith R., Praparattanapan J., Nuntachit N., Kotarathitithum W., Sirisanthana T., Supparatpinyo K. |
---|---|
Format: | Article |
Language: | English |
Published: |
2014
|
Online Access: | http://www.scopus.com/inward/record.url?eid=2-s2.0-79953320243&partnerID=40&md5=54dab00f2eaa4d1085c596d2db5a077d http://www.ncbi.nlm.nih.gov/pubmed/21361862 http://cmuir.cmu.ac.th/handle/6653943832/2699 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Language: | English |
Similar Items
-
Impact of the frequency of plasma HIV-1 RNA monitoring on the outcome of antiretroviral therapy
by: Romanee Chaiwarith, et al.
Published: (2018) -
Resistance-associated mutations after initial antiretroviral treatment failure in a large cohort of patients infected with HIV-1 Subtype CRF01_AE
by: Praparattanapan,J., et al.
Published: (2015) -
Resistance-Associated Mutations after Initial Antiretroviral Treatment Failure in a Large Cohort of Patients Infected with HIV-1 Subtype CRF01_AE
by: Praparattanapan J., et al.
Published: (2014) -
Discontinuation of primary and secondary prophylaxis for opportunistic infections in HIV-infected patients who had CD4+ cell count <200 cells/mm(3) but undetectable plasma HIV-1 RNA: an open-label randomized controlled trial
by: Chaiwarith R., et al.
Published: (2014) -
Discontinuation of primary and secondary prophylaxis for opportunistic infections in HIV-Infected Patients Who Had CD4+ Cell Count <200 cells/mm3 but Undetectable Plasma HIV-1 RNA: An Open-Label Randomized Controlled Trial
by: Romanee Chaiwarith, et al.
Published: (2018)